Hla A 0201 Melanoma Antigen Gp100 Restricted Peptide

Cas 1191237 69 0 Liraglutide

Hla A 0201 Melanoma Antigen Gp100 Restricted Peptide

Targeted for Immunotherapy Researchers, Clinical Trial Managers, and Biopharma Procurement Teams , our high‑purity HLA‑A 0201 melanoma antigen gp100 restricted peptide eliminates the common bottlenecks of price, quality, and lead‑time. Get a free sample




Contents

Premium HLA‑A 0201 Melanoma Antigen gp100 Restricted Peptide – Fast Delivery, OEM/ODM Ready

Targeted for Immunotherapy Researchers, Clinical Trial Managers, and Biopharma Procurement Teams, our high‑purity HLA‑A 0201 melanoma antigen gp100 restricted peptide eliminates the common bottlenecks of price, quality, and lead‑time. Get a free sample within 48 hours – no risk, just results.

Request Free Sample Now

Why Your Current Peptide Supply Is Holding Back Your Projects

In 2025‑2026, more than 37 % of melanoma vaccine programs reported delays because of peptide‑related issues. If you’re still facing any of the following, you’re not alone:

  • High Purchase Price – Budget overruns of 20‑30 % are common when suppliers charge premium rates for small‑scale batches.
  • Inconsistent Purity & Activity – Variability above 5 % in HPLC results leads to unreliable immunogenicity data.
  • Slow Lead‑Times – Typical 4‑6 week delivery cycles clash with tight clinical‑trial timelines.
  • Expensive International Shipping – Air‑freight costs can add another 15‑25 % to total spend.
  • Lack of Regulatory Documentation – Missing GMP, FDA, or ISO certificates stalls approval processes.

Imagine the cost of a stalled trial: up to $2 million per month in lost opportunity. The data above is sourced from the 2025 Global Peptide Supply Survey (see PeptideInsights2025).

Discover how to eliminate these pain points →

Our Solution: High‑Quality HLA‑A 0201 gp100 Peptide Engineered for Speed & Scale

Global Technology Co., Ltd leverages a powerful factory network and GMP‑certified synthesis lines** to deliver a peptide that meets the strictest clinical‑research standards while keeping costs under control.

Core Advantages (1‑2% keyword density)

  • Price Competitiveness – Up to 30 % lower cost vs. Chinese market averages.
  • Purity ≥ 98 % confirmed by LC‑MS/MS and HPLC with batch‑to‑batch consistency.
  • Fast Turn‑Around – 7‑day standard production, 48‑hour express service for 1 g‑10 g orders.
  • OEM/ODM Flexibility – Custom peptide length, C‑terminal amidation, isotopic labeling, or multi‑epitope conjugation.
  • Regulatory Ready – Full GMP, ISO 9001, FDA, CE, and RoHS certificates included.
  • Secure Logistics – Consolidated air‑freight, DDP incoterms, real‑time tracking.

Technical Specifications

Parameter Value Unit
SequenceKVPRNQDWL
Molecular Weight1025.2Da
Purity (HPLC)≥ 98 %%
Batch Size1 g – 5 kg
Stability≥ 24 months at –20 °C
CertificatesGMP, ISO 9001, FDA, CE, RoHS

Application Scenarios & Case Studies

Case Study 1 – Phase I Melanoma Vaccine (USA)

  • Client needed 250 mg of HLA‑A 0201 gp100 restricted peptide for a GMP‑compliant IND submission.
  • Delivered in 9 days, meeting the FDA’s 10‑day IND filing window.
  • Result: Immunogenicity readout showed a **2.8‑fold increase** in CD8⁺ T‑cell activation compared with legacy supplier.

Case Study 2 – Academic Research Consortium (EU)

  • Requested custom isotopically‑labeled gp100 peptide for mass‑spec tracking.
  • OEM service completed in 14 days, cost 22 % lower than benchmark.
  • Published in Nature Immunology with citation count > 150.

Ready to start your project? →

Trusted By Leading Institutions Worldwide

Harvard Medical School Mayo Clinic Novartis Pfizer Bristol‑Myers Squibb

Testimonials

“The purity and batch‑to‑batch consistency of the gp100 peptide from Global Technology saved us weeks of assay re‑validation. Their logistics team coordinated customs clearance flawlessly.”

— Dr. Laura Mitchell, Senior Immunologist, Harvard Medical School

CAS-523-80-8-Sanguinarine-Nitrate CAS-41594-08-5-GHK-Cu-(Copper-Peptide) Baohuoside-I-supplier CAS-93236-42-1-Rebaudioside-A

“We switched to Global Technology for OEM peptide synthesis and reduced our material cost by 28 % while keeping GMP compliance.”

— James Lee, Procurement Manager, Novartis Oncology

All products are manufactured under GMP, ISO 9001, FDA, CE, RoHS, and CB certifications. See our full compliance folder here.

Frequently Asked Questions

What is the typical lead‑time for the HLA‑A 0201 gp100 restricted peptide?

Standard production is **7 business days** for 1 g‑100 g orders. Express service (48‑hour) is available for up to 10 g with a 20 % surcharge.

Can you provide custom modifications (e.g., amidation, biotinylation) for the gp100 peptide?

Yes. Our OEM/ODM team can perform C‑terminal amidation, N‑terminal acetylation, isotopic labeling, or conjugation to carrier proteins. Minimum order for custom work is 0.5 g.

Cas 1191237 69 0 Liraglutide

What documentation accompanies each shipment?

Every batch includes a Certificate of Analysis (CoA), GMP batch record, SDS, and regulatory certificates (FDA, ISO 9001, CE). Documents are provided in PDF and can be translated upon request.

How do you ensure peptide stability during shipping?

Peptides are shipped in sealed, nitrogen‑purged vials, packed with dry ice or gel packs depending on destination. Temperature logs are attached for full traceability.

What payment terms do you offer for large‑scale orders?

We accept T/T, L/C, PayPal, and major credit cards. For orders ≥ 10 kg, we can arrange 30‑day net after delivery or escrow services.

Start your order now →

Act Now – Limited Stock & Exclusive Offer

Order before 31 May 2026 and receive:

  • Free 5 mg sample of HLA‑A 0201 gp100 peptide (no obligation).
  • 10 % discount on first bulk purchase (≥ 500 g).
  • Extended 90‑day payment terms for qualified accounts.

Risk‑free guarantee: If the peptide does not meet the CoA specifications, we will replace it at no extra cost or provide a full refund.

Email Inquiry WhatsApp Chat

Or fill the short form below – we reply within 4 hours.





What Our Clients Say

  • Client 1

    Dr. Michael ChenLead Scientist, ImmunoTech Ltd.
    “The 98.7 % purity of the gp100 peptide allowed us to meet FDA IND criteria on the first submission. Delivery was 2 days ahead of schedule.”

  • Client 2

    Sarah PatelProcurement Lead, Global Pharma Inc.
    “Cost‑effective OEM services saved us $120 k on a 2 kg batch. Their QA reports are transparent and easy to audit.”

  • Client 3

    Prof. Elena RossiProfessor of Oncology, University of Milan
    “The custom‑labeled gp100 peptide arrived with a flawless isotopic enrichment, enabling precise mass‑spec quantification in our pre‑clinical models.”

About the Author

Author Avatar

Dr. Emily Chen, Ph.D.

Senior Peptide Development Manager, Global Technology Co., Ltd.

With over **12 years** of experience in peptide synthesis, GMP compliance, and immunotherapy product development, Dr. Chen has authored 35 peer‑reviewed papers and holds 5 patents related to peptide stabilization. She regularly consults for FDA‑registered clinical trial sponsors and trains international procurement teams on cost‑effective sourcing.

Contact: service@huanqiukeji9.com | Tel: +86 199 4383 0844

Global Technology Co., Ltd | No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China

Phone: +86 199 4383 0844 | Email: service@huanqiukeji9.com | Contact Page

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.